ZA200800339B - Pharmaceutical formulations for minimizing drug-drug interactions - Google Patents

Pharmaceutical formulations for minimizing drug-drug interactions

Info

Publication number
ZA200800339B
ZA200800339B ZA200800339A ZA200800339A ZA200800339B ZA 200800339 B ZA200800339 B ZA 200800339B ZA 200800339 A ZA200800339 A ZA 200800339A ZA 200800339 A ZA200800339 A ZA 200800339A ZA 200800339 B ZA200800339 B ZA 200800339B
Authority
ZA
South Africa
Prior art keywords
drug
pharmaceutical formulations
minimizing
interactions
drug interactions
Prior art date
Application number
ZA200800339A
Other languages
English (en)
Inventor
Barrett E Rainbow
Cook Chyung
Gupta Pramod
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of ZA200800339B publication Critical patent/ZA200800339B/xx

Links

ZA200800339A 2005-06-14 2008-01-11 Pharmaceutical formulations for minimizing drug-drug interactions ZA200800339B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69032205P 2005-06-14 2005-06-14

Publications (1)

Publication Number Publication Date
ZA200800339B true ZA200800339B (en) 2008-12-31

Family

ID=39226570

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800339A ZA200800339B (en) 2005-06-14 2008-01-11 Pharmaceutical formulations for minimizing drug-drug interactions

Country Status (3)

Country Link
CN (1) CN101212981A (xx)
NO (1) NO20080188L (xx)
ZA (1) ZA200800339B (xx)

Also Published As

Publication number Publication date
NO20080188L (no) 2008-01-11
CN101212981A (zh) 2008-07-02

Similar Documents

Publication Publication Date Title
IL187511A0 (en) Lipases for pharmaceutical use
GB0501999D0 (en) Pharmaceutical compounds
GB0520657D0 (en) Pharmaceutical compounds
GB0520656D0 (en) Pharmaceutical compounds
ZA200708705B (en) Pharmaceutical composition
IL187339A0 (en) Pharmaceutical formulations for minimizing drug-drug interactions
GB0523810D0 (en) Pharmaceutical compositions
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
EP1862184A4 (en) PHARMACEUTICAL COMPOSITION
GB0522045D0 (en) Pharmaceutical compositions
GB0512643D0 (en) Pharmaceutical compounds
GB0521612D0 (en) Storage system for texaphyrin pharmaceutical formulations
IL198160A0 (en) Pharmaceutical formulations
EP1845944A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA200705612B (en) Pharmaceutical compounds
GB0514259D0 (en) Pharmaceutical compositions
ZA200800339B (en) Pharmaceutical formulations for minimizing drug-drug interactions
GB0501475D0 (en) Pharmaceutical compounds
GB0515937D0 (en) Pharmaceutical formulation
GB0615461D0 (en) Pharmaceutical formulations
ZA200803112B (en) Pharmaceutical composition
ZA200800392B (en) Pharmaceutical composition
GB0500138D0 (en) Pharmaceutical composition
GB0504276D0 (en) Pharmaceutical composition
GB0511801D0 (en) Pharmaceutical composition